M
20
-4
NWSA
62
2
JPM
63
-4
MKC
56
8
HON
65
-2
FRT
39
-2
COP
56
2
JWN
40
-2
ED
48
3
URBN
38
-4
ACN
47
-2
FOXA
55
9
DHR
35
3
GOOGL
54
-2
NOV
58
3
DVA
72
2
PPL
54
2
ROK
55
8
TGNA
53
2
IVZ
46
3
M
20
-4
NWSA
62
2
JPM
63
-4
MKC
56
8
HON
65
-2
FRT
39
-2
COP
56
2
JWN
40
-2
ED
48
3
URBN
38
-4
ACN
47
-2
FOXA
55
9
DHR
35
3
GOOGL
54
-2
NOV
58
3
DVA
72
2
PPL
54
2
ROK
55
8
TGNA
53
2
IVZ
46
3
Financhill
Back

Arcutis Biotherapeutics Vs. Vertex Pharmaceuticals Industry Stock Comparison

Sell
26

ARQT
Arcutis Biotherapeutics

Last Price:
10.24
Seasonality Move:
101.78%
Sell
46

VRTX
Vertex Pharmaceuticals

Last Price:
450.38
Seasonality Move:
11.1%
Sell
26
Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $10.18. The Score for ARQT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • ARQT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $451.23. The Score for VRTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $10.18
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing slight buying pressure.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $451.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 56.5 Buy
Chaikin Money Flow: 20888 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.47 - 10.17) Buy
Bollinger Bands (100): (8.97 - 10.47) Buy

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.34 Sell
Relative Strength Index (14 RSI): 38.05 Sell
Chaikin Money Flow: 1367870 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (464.53 - 495.47) Sell
Bollinger Bands (100): (465.6 - 492.12) Sell

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.06 Buy
20-day SMA: 9.48 Buy
50-day SMA: 9.6 Buy
200-day SMA: 9.45 Buy
8-day EMA: 9.93 Buy
20-day EMA: 9.7 Buy
50-day EMA: 9.6 Buy
200-day EMA: 9.14 Buy

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 475.28 Sell
20-day SMA: 480.34 Sell
50-day SMA: 474.92 Sell
200-day SMA: 453.64 Sell
8-day EMA: 469.24 Sell
20-day EMA: 476.78 Sell
50-day EMA: 476.74 Sell
200-day EMA: 452.69 Sell

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.53 per share, and an increase next year of $18.37 per share.

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):